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ntegrin-mediated adhesion promotes cell survival in
vitro, whereas integrin antagonists induce apoptosis of
adherent cells in vivo. Here, we demonstrate that cells
adherent within a three-dimensional extracellular matrix
undergo apoptosis due to expression of unligated inte-
 
grins, the 
 
 
 
 subunit cytoplasmic domain, or its mem-
brane  proximal sequence KLLITIHDRKEF. Integrin-medi-
ated death requires initiator, but not stress, caspase activity
I
 
and is distinct from anoikis, which is caused by the loss
of adhesion per se. Surprisingly, unligated integrin or 
 
 
 
 inte-
grin tails recruit caspase-8 to the membrane, where it be-
comes activated in a death receptor–independent manner.
Integrin ligation disrupts this integrin–caspase containing
complex and increases survival, revealing an unexpected
role for integrins in the regulation of apoptosis and tissue re-
modeling.
 
Introduction
 
Integrins are cell adhesion receptors that mediate cell sur-
vival, proliferation, and migration in response to cues from
the surrounding extracellular matrix (ECM)* (Hynes, 1992;
Giancotti and Ruoslahti, 1999). These extracellular cues are
transmitted into the cells through the direct or indirect
interactions of integrins with a diverse array of cytosolic
mediators, including protein and lipid kinases (Auer and
Jacobson, 1995; Hauck et al., 2001), adaptor proteins
(Wary et al., 1996; Cho and Klemke, 2000), and other
modulatory proteins (Du et al., 1995; Scatena et al., 1998).
Integrin expression is regulated in response to cellular ac-
tivation by a variety of agents, including growth factors
and cytokines (Eliceiri et al., 1998), and is crucial to tissue
remodeling events, such as wound healing, inflammation,
reproductive cycling, and tumor establishment (Murray and
Lessey, 1999; Tarone et al., 2000).
Unlike cytokine receptors, however, integrins function
selectively as “solid state” receptors (Ingber, 1992). Whereas
a substrate-immobilized ligand can serve as an integrin
agonist, the same ligand in solution functions as an integrin
antagonist. This characteristic of the integrin may relate to
an altered capacity of the integrins to cluster (Broday, 2000),
recruit kinases such as focal adhesion kinase (Hildebrand et
al., 1993), tether adaptor proteins and cytoskeletal elements
(Wary et al., 1996), and/or provide mechanical tension
(Hocking et al., 2000). Irrespective of the mechanism, it is
clear that both of these distinct integrin states provide infor-
mation to the cell about the nature of its environment.
For example, de novo expression of integrin 
 
 
 
v
 
 
 
3 occurs
on endothelial cells in response to angiogenic growth factors
(Brooks et al., 1994a), allowing increased endothelial cell in-
teraction with the deposited provisional ECM. Soluble an-
tagonists of this receptor initiate endothelial cell apoptosis,
suppressing angiogenesis in various animal models (Brooks
et al., 1994b; Storgard et al., 1999). Notably, cell death does
not result from the loss of adhesion, per se, as observed during
anoikis (Frisch and Francis, 1994). Instead, apoptosis results
from the selective blockade of a single integrin, in this case
 
 
 
v
 
 
 
3, on adherent, tissue-associated cells. Similar observa-
tions have been made involving other integrins. Notably, the
overexpression of unligated integrin 
 
 
 
5
 
 
 
1 has been associ-
ated with apoptosis and reduced tumor cell growth in vitro
and in vivo (Giancotti and Ruoslahti, 1990; Varner et al.,
1995; Kim et al., 2000; Plath et al., 2000). These observa-
tions suggest that the expression of specific integrin com-
plexes, in the absence of a suitable ligand, may promote
death. Physiologically, this would provide a mechanism
whereby cells that find themselves within an inappropriate
ECM would be actively cued to undergo apoptosis.
To understand how integrins, in the ligated or unligated
state, influence cell survival in a physiological environment,
cells with a defined integrin profile were evaluated in the
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context of a homogenous three-dimensional ECM. The evi-
dence provided demonstrates that simple expression of unli-
gated integrin is sufficient to initiate cell death among ad-
herent cells. This “integrin-mediated death” (IMD) was
similarly induced by the cytoplasmic domain of 
 
 
 
1 or 
 
 
 
3 in-
tegrins, resulting in the recruitment of caspase-8 to the cell
membrane and its subsequent activation. These results reveal
an unexpected role for integrins as proactive mediators of cell
death, and document a novel mechanism for the induction
of apoptosis during tissue remodeling and homeostasis.
 
Results
 
The expression of unligated integrins leads to cell 
death in ECM-associated cells
 
It is evident that cell adhesion occurs in vivo among cells
that are otherwise ECM adherent. To evaluate the effect of
integrin ligation state upon the survival of adherent cells, we
examined the 
 
 
 
v
 
 
 
3-expressing carcinoma, T24E, in a three-
dimensional collagen ECM (Ilan et al., 1998). Collagen pro-
vides a ligand for specific 
 
 
 
1 integrins, e.g., 
 
 
 
1
 
 
 
1, 
 
 
 
2
 
 
 
1,
and 
 
 
 
3
 
 
 
1, (Takada et al., 1988) but not for 
 
 
 
v
 
 
 
3 (Filardo
et al., 1995), expressed on these cells. Within 48–72 h of
collagen culture, T24E cells became apoptotic, exhibiting
extensive blebbing, annexin-V staining, and nuclear col-
lapse. In contrast, T24E cells sorted for the lack of integrin
 
 
 
v
 
 
 
3 (T24E-L; Fig. 1 A) exhibited increased survival in this
matrix (approximately twofold greater survival at 72 h; Fig.
1 B). To assess whether the 
 
 
 
v
 
 
 
3 expression level was re-
sponsible for these events, T24E-L cells were genetically re-
constituted with 
 
 
 
v
 
 
 
3 (T24E-L
 
 
 
3). This resulted in accel-
erated cell death (50% death in 24 h vs. 72 h in the T24E-L
cells lacking 
 
 
 
v
 
 
 
3; Fig. 1 B, left), suggesting that 
 
 
 
v
 
 
 
3 po-
tentiates the death of these cells within this ECM. Impor-
tantly, the expression of 
 
 
 
v
 
 
 
3 was not generally deleterious
to the cells. All of the T24 lines proliferated at a similar rate
and exhibited comparable basal apoptotic rates (unpublished
data). The expression of integrin 
 
 
 
v
 
 
 
3 was not generally
harmful, since it conferred a survival advantage when
growth factors were withdrawn (Fig. 1 B, right), resulting in
a significant decrease in cell death. Thus, the expression of
 
 
 
v
 
 
 
3 is associated with cell death only in the absence of an
appropriate ligand.
To extend these observations, we next examined the an-
chorage-independent CS1 melanoma cell line, which sur-
vives and proliferates in suspension and, as such, exhibits no
requirement for integrin-mediated signaling to maintain via-
bility. However, CS1
 
 
 
3 cells, which have reconstituted ex-
pression of integrin 
 
 
 
v
 
 
 
3 (Filardo et al., 1995), underwent
apoptosis when deprived of an 
 
 
 
v
 
 
 
3 ligand by culture on
collagen gels or in suspension culture (Fig. 1 C), whereas pa-
rental CS1 cells did not. In this case, simple expression of
unligated 
 
 
 
v
 
 
 
3 was proapoptotic, thus overcoming the an-
chorage-independent phenotype of these cells. These results
reveal that the expression of an integrin, in this case 
 
 
 
v
 
 
 
3,
can induce apoptosis in the absence of an appropriate ligand.
Endothelial cells survive when cultured in fibrin, an ECM
that ligates integrin 
 
 
 
v
 
 
 
3 and at least two 
 
 
 
1 integrins, yet
undergo apoptosis when cultured in collagen (Fig. 2 A) (Fi-
lardo et al., 1995). Similarly, endothelial cells undergo apop-
tosis when cultured on the surface of collagen gels, but not
on fibrin gels (Fig. 2 A, open bars). The induction of death
was not simply due to an inability to attach and spread on
collagen, since endothelial spreading on collagen and fibrin
occurred to the same degree and with similar kinetics (Fig. 2
B). However, endothelial cells cultured on collagen were
Figure 1. Expression of integrin  v 3 increases death among cells 
attached to an ECM that does not ligate  v 3. (A) T24E-L cells 
were derived from T24E cells by serial sorting to select a  3-lacking 
population. The T24E-L 3 cells, derived from T24E-L, were 
genetically reconstituted for  v 3 expression. The relative  v 3 
integrin expression in these lines is shown by flow cytometry using 
monoclonal antibody LM609 (histograms), and by immunoblotting 
for the  3 integrin subunit with monoclonal antibody AP3 (inset). 
(B) Survival of these cell variants during culture in a collagen gel in 
the presence of serum (left) was determined. Death was scored by 
apoptotic morphology (condensation, satellite array; Cho and 
Klemke, 2000). Cell survival shown represents the mean   SE of 
triplicate wells from a representative experiment. The viability of 
T24E, T24E-L, and T24E-L 3 cells were also assessed following 
serum deprivation (right). Viability was determined by immunofluo-
rescent, microscopic assessment of PI exclusion at progressive time 
points. Data shown are from a representative experiment, and 
represent the mean   SE viability of triplicate wells. (C) The stable 
expression of integrin  v 3 in the CS1 3 cell line has been previ-
ously described (Filardo et al., 1995). CS1 parental cells (lacking 
 v 3) or CS1 3 cells were grown as adherent to tissue culture 
(control CS1 3, black histogram), collagen cultured (gray histo-
grams), or held in suspension (white histograms). After 20 h in com-
plete media, cells were assessed for apoptosis by annexin-V staining 
and FACS
® analysis. A representative experiment, of two, is shown. 
Apoptosis of adherent cells by unligated integrins |
 
 Stupack et al. 461
 
prone to apoptosis, leading to laemelopod retraction, blebbing,
nuclear condensation, and eventual detachment.
To establish whether the presence of endogenous 
 
 
 
v
 
 
 
3 on
these cells contributed to this apoptotic event, an antisense
strategy was used to suppress endogenous 
 
 
 
v
 
 
 
3 integrin ex-
pression (Dallabrida et al., 2000). Decreasing the level of
 
 
 
v
 
 
 
3 on these cells (40–60%; Fig. 2 C) resulted in a signifi-
cant increase (twofold) in survival in collagen (Fig. 2 D,
left), without significantly influencing survival in fibrin (Fig.
2 D, right) or cell adhesion to fibronectin, laminin, vitro-
nectin, and, importantly, collagen (Fig. 2 E). As a second
means to assess the role of integrins in cell survival, mono-
clonal antibodies directed against integrins 
 
 
 
v
 
 
 
3 or 
 
 
 
1 were
used as antagonists of integrin function. In this case, inter-
fering with 
 
 
 
1 integrin function accelerated apoptosis in col-
lagen gels (Fig. 2 F, left), whereas blockade of either 
 
 
 
1 or
 
 
 
v
 
 
 
3 decreased survival in fibrin gels (Fig. 2 F, right). This
result is consistent with previous observations that both
 
 
 
v
 
 
 
3 and 
 
 
 
5
 
 
 
1 bind fibrin (Yee et al., 2001). Together,
these results indicate that a reduction of endogenous, unli-
gated integrin expression can suppress apoptosis in ECM-
attached cells, whereas an increase in integrin expression ac-
tively promotes apoptosis. The capacity to promote survival
when ligated but to induce apoptosis when unligated is a
hallmark of dependence receptors, such as nerve growth fac-
tor receptor, p75NGFR, and the netrin receptor, DCC
(Bredesen et al., 1998; Mehlen et al., 1998). Our findings
suggest that integrins may similarly be considered depen-
dence receptors.
 
The cytoplasmic domain of the integrin 
 
 
 
 subunit 
is proapoptotic
 
Integrin-mediated signaling depends largely on the cytoplas-
mic domains of the 
 
 
 
 and 
 
 
 
 subunits. To determine
whether the integrin cytoplasmic domain was sufficient to
induce death, chimeric proteins composed of the extracellu-
lar domain of CD25 (IL2Ra, Tac) and the cytoplasmic do-
mains of either integrin 
 
 
 
5, 
 
 
 
1, or 
 
 
 
3 (LaFlamme et al.,
1992) were expressed in COS7 cells. The expression of ei-
ther Tac-
 
 
 
1 or Tac-
 
 
 
3 constructs resulted in increased
death, while expression of the 
 
 
 
5 chimera did not (Fig. 3 A),
despite similar expression levels (Fig. 3 B). Tac-
 
 
 
3 expres-
sion produced a dose-dependent death among attached cells
(Fig. 3 B). Importantly, the expression of these integrins was
similar to, or less than, that of native integrins. Death oc-
curred via apoptosis, as indicated by annexin-V reactivity
(Fig. 3 C, top) and by processing of the caspase substrate,
poly (ADP-ribose) polymerase (PARP), to the characteristic
Figure 2. Decreasing the expression of 
endogenous integrin  v 3 reduces 
endothelial cell apoptosis during 
collagen culture. (A) Endothelial cells 
undergo apoptosis when cultured in a 
three-dimensional collagen matrix in the 
presence of complete media. HUVECs 
were labeled with Cell Tracker green (2 
 M) and cultured in a three-dimensional 
collagen gel, fibrin gel, or in suspension 
(filled bars) or, alternatively, on the 
surface of collagen or fibrin gels (open 
bars) for 24 h. ECM-associated cells 
were scored for apoptosis by the 
morphological analysis of digital images. 
A representative experiment is shown, 
each bar is the mean survival,   SE, of 
six low power fields. (B) Cell spreading 
was assessed in HUVECs attached to the 
surface of collagen (Col) or fibrin (Fb) 
gels (right) after capture of digital images 
of Cell Tracker–labeled cells (left). Cells 
were segmented and area calculated 
using IP Lab software. Data shown for 
each point is the mean   SE cell area 
calculated at each time point from 10 
low power fields. (C) The effect of 
treatment with a human-specific  3 
integrin antisense gene, delivered by adenovirus (AdAS 3), or that of a control, nonsense adenovirus (AdNS), upon the expression of native 
 v 3 in HUVECs was determined using LM609 for FACS
® analysis and AP3 for immunoblotting (inset) as described in Fig. 1 A. (D) AdAS 3-
treated (or AdNS-treated) HUVECs were assessed for the percentage of surviving cells after a 24 h culture in a three-dimensional collagen gel 
(left) or fibrin gels (right) as described above. The results shown are the mean   SE of two fibrin or four collagen experiments. (E)  3 
antisense–treated HUVECs exhibited normal levels of ECM attachment. AdAS 3-treated HUVECs (filled bars) were assessed for adhesion to 
wells coated with ECM components vitronectin (VN), fibronectin (FN), laminin (LN), and collagen (COL). Adhesion was quantitated by 
staining of attached cells with crystal violet, followed by washing, reextraction, and quantitation of the bound dye (Filardo et al., 1995), and 
expressed relative to untreated HUVECs. AdNS-treated HUVECs (open bars) are shown as controls. The mean   SE of two independent 
experiments is shown. (F) HUVEC survival was examined in collagen (left) or fibrin (right) gels, as described above, in the presence of 
30  g/ml monoclonal antibody P4C10 (anti- 1 integrin), monoclonal antibody LM609 (anti- v 3 integrin), both antibodies, or control 
monoclonal antibody 7G7B6 (anti-CD25). Survival shown is significantly decreased at 24 h (P   0.05) in both ECMs in the presence of 
P4C10 or both antibodies. One of two similar experiments is shown.462 The Journal of Cell Biology | Volume 155, Number 3, 2001
85-kD apoptotic fragment (Fig. 3 C, bottom). IMD was in-
duced efficiently by Tac- 3 or Tac- 1, yet only weakly by
Tac- 5 (Fig. 3 D).
A membrane-proximal sequence in the integrin tail is 
sufficient to induce apoptosis in attached cells
As an initial means to address the regions of the   integrin
tail required for IMD, successive truncations were made in
the cytoplasmic domain of Tac- 3 (Fig. 4 A). Cells express-
ing each of the truncated constructs were analyzed for cell
death by propidium iodide (PI) exclusion (Fig. 4 B), and for
the activation of executioner caspases as indicated by PARP
cleavage (Fig. 4 C). A minimal sequence required to induce
apoptosis was identified within the membrane-proximal se-
quence of  3 718–727, KLLITIHDRKEF (Fig. 4, B and
C). Interestingly, this region is insufficient to mediate sig-
naling through previously characterized survival pathways,
including via Src, Shc, or focal adhesion kinase (Wary et al.,
1996; Tahiliani et al., 1997; Hauck et al., 2001). Thus, it is
unlikely that IMD proceeds by the disruption of known sur-
vival signaling pathways.
A number of regions of the integrin tail have been impli-
cated in the induction of signaling by integrins. In particu-
lar, the NPXY site,  3 744–747, has been identified as a
critical motif involved in signaling downstream of integrin
 3 (Filardo et al., 1995; Liu et al., 2000). In agreement, a
mutant  3 integrin constructed with a loss of function mu-
tation in this region (N744A) expressed in T24E-L cells
(T24E-L744) resulted in complete loss of  v 3-mediated
migration (Fig. 4 D, left). However, this mutant still in-
duced the IMD of cells within a three-dimensional collagen
matrix (Fig. 4 D, right). Together, the results indicate that
divergent mechanisms are required for IMD and “classical”
integrin signaling. Membrane localization of the  3 tail ap-
peared to be required to initiate IMD, since expression of
the integrin tail without a transmembrane domain (His- 3)
failed to cause death (Fig. 4 E), whereas expression of a sec-
ond membrane-anchored integrin construct (green fluores-
cent protein [GFP]- 3) led to PARP cleavage (Fig. 4 E) and
apoptosis. This finding provides further evidence that inte-
grin expression does not cause death in a simple “dominant
negative” manner.
The expression of GFP- 3 also allowed integrin-trans-
fected cells to be monitored to assess whether cell spreading
was compromised. In agreement with the previous endothe-
lial cell spreading studies (Fig. 2 B), no difference in cell
spreading was observed between GFP- 3 and control GFP-
expressing cells until after apoptosis was evident (Fig. 4 F).
Figure 3. The integrin cytoplasmic 
domain is sufficient to induce apoptosis. 
(A) Chimeric constructs composed of the 
cytoplasmic domains of integrins  5, 
 1, or  3 and the extracellular and 
transmembrane regions of CD25 (Tac) 
were expressed in COS7 cells, and 
viability of cells positive for Tac expres-
sion (FITC-7G7B6 positive) was deter-
mined via PI exclusion 36 h later. (B) 
Analysis of the effect of increasing 
expression of Tac- 3 or control Tac- 5 
on cell viability was performed. As 
shown,  25–35% of all cells expressed 
elevated Tac (top, MED and HI popula-
tions). To quantitate death, transfected 
cells were separated based on mean 
fluorescence intensity (LO, MED, and 
HI; top). The viability of these popula-
tions was determined by PI exclusion 
(bottom). Approximately 30–50% of the 
total Tac- 3–expressing cells (MED and 
HI) die during the course of the assay, or 
 8–16% of the total COS7 cell popula-
tion. (C) Tac- 3–expressing COS7 cells 
exhibited classic apoptotic markers.
18 h after transfection, nonadherent 
cells were removed and discarded; only 
those remaining attached were assessed 
for the onset of apoptosis by staining 
with annexin-V–FITC (top). Each bar 
represents the mean percentage of 
annexin-positive cells (  SE) from three independent experiments. The cleavage of the executioner caspase substrate PARP was assessed by 
Western blotting of total cell lysates 36 h after transfection. Caspase-cleaved PARP was detected as the 85-kD fragment that is characteristic 
of apoptosis (bottom). The relative intensity of the cleaved fragment was quantitated as a ratio relative to the uncleaved PARP, including 
PARP from nonexpressing cells, to give a relative indication of the activation of executioner caspases. The derived PARP ratios shown are: 
lipofectamine control, 0.004; Tac- 3, 0.17. (D) Caspase activity, as measured by the relative cleavage of PARP, was determined as a dose-
dependent quantity of pCI-NeoTac transfection. COS7 cells were transfected with cDNA-encoding integrin tail constructs. Approximately 
25–40% of cells expressed Tac, and comparable expression was observed between constructs at each dose transfected. The effect of express-
ing Tac- 1, Tac- 3, and the control, Tac- 5, as well as a chimera expressing the cytoplasmic domain of  5 (Tac- 5) was determined as the 
mean   SE of caspase activity (measured as the intensity of p85/p115 from three independent experiments, as described above).Apoptosis of adherent cells by unligated integrins | Stupack et al. 463
Thus, the onset of apoptosis can initiate cell retraction and
eventual detachment (Harrington et al., 2001).
Integrin-mediated substrate attachment, accomplished by
adhesion to ECM proteins (Ilic et al., 1998; Scatena et al.,
1998) or by integrin binding to substrate-immobilized anti-
bodies (Stromblad et al., 1996), suppresses apoptosis. In
contrast, antagonized (Brassard et al., 1999) and/or nonli-
gated integrins (Stromblad et al., 1996; and this manuscript)
promote apoptosis among otherwise adherent cells. To eval-
uate whether the integrin chimeras would promote death
when substrate-immobilized, Tac- 3–expressing COS7 cells
were replated on surfaces coated with an anti-Tac mono-
clonal antibody. This attachment and cell spreading en-
riched the number of integrin chimera–expressing cells (Fig.
4 G, top), yet these cells demonstrated a dramatic reduction
in apoptosis (60% decrease in PARP cleavage) relative to the
adherent control population (Fig. 4 G, bottom). In other ex-
periments, we also tested whether cells treated with soluble
anti-Tac or anti-Tac on microbeads could prevent IMD, but
neither impacted this event (unpublished data). Our result
suggests that only substrate-localized integrin “clustering”
was capable of suppressing the death-promoting activity of
the  3 tail.
IMD requires initiator caspases
To begin to address the molecular mechanism responsible
for IMD, checkpoint-specific inhibitors of caspase activation
were expressed in COS7 cells undergoing IMD. Expression
of dominant negative caspase-9 or bclxl, which inhibit the
stress-mediated caspase cascade (Finucane et al., 1999; Soen-
gas et al., 1999; Wolf and Green, 1999), did not prevent
IMD, but did block stress-induced apoptosis of these cells
(Fig. 5 A). In contrast, crmA, a serpin that inhibits activa-
tion by death receptor–activated caspases (Zhou et al.,
1997), protected cells from IMD (Fig. 5, A and B). Surpris-
ingly, a negative-acting variant of the death receptor adap-
tor, FADD (Fas-associating protein with death domain),
which inhibits Fas-initiated apoptosis mediated by death re-
ceptors (Chinnaiyan et al., 1996), was not protective (Fig. 5,
A and B), despite the fact that it effectively blocked the Fas-
mediated death of these cells (Fig. 5 A). Apoptosis could also
be prevented by treatment of integrin tail–expressing cells
with peptide inhibitors of initiator and executioner caspases
(Fig. 5 C) (Thornberry et al., 1997), but was unaffected by a
stress caspase–selective inhibitor (zLEHDfmk).
To confirm that the apoptotic pathways initiated by the
integrin chimeras were the same as those induced by endoge-
nous integrins, COS7 cells expressing these checkpoint spe-
cific inhibitors were examined for their survival on collagen
expressing GFP- 3 or GFP-TM (control, GFP with a signal sequence 
and the transmembrane domain from CD25) as described above 
(Fig. 2 B) 12, 24, and 48 h after transfection. (G) Ligation of  3 
constructs suppresses IMD. COS7 cells expressing submaximal 
levels of integrin tails were allowed to attach to substrates coated with 
anti-Tac monoclonal antibody (Ligation  ) or maintained as a nor-
mal, adherent tissue culture (Ligation  ). Adherent cells were lysed 
and assessed for the relative expression of death-inducing construct, 
i.e., integrin, present, as well as to determine executioner caspase 
activation (through quantitation of p85/p115 ratios) via immunoblot 
analysis. Bars represent the mean   SE of three experiments.
Figure 4. IMD requires a membrane localized region of the integrin 
cytoplasmic domain. (A) A series of mutant integrin chimeras with 
truncations of the native integrin  3 cytoplasmic domain (residues 
715–762) and the extracellular domain of Tac were constructed in 
pCI-Neo and expressed in COS7 cells. (B) Expression of integrin tail 
mutant constructs leads to cell death. COS7 cells expressing the 
integrin constructs were assessed for viability based on PI exclusion 
by flow cytometry. Within each experiment, the relative capacity of 
each construct to induce death was normalized to the death 
induced by the full length tail (which ranged from 20 to 40% of 
expressing cells in these studies). (C) Executioner caspase activity is 
induced by integrin truncation mutants. For each mutant, the 
relative caspase activation (assessed by the p85/p115 ratio) was 
assessed and normalized to that induced by intact Tac- 3. The 
results shown are the mean   SD of the normalized PARP ratios for 
three experiments. (D) Mutation of the NPXY motif within the tail of 
integrin  3 blocks  v 3-directed cell migration, but does not inhibit 
IMD. T24-EL cells reconstituted to express wild type  3 (T24-EL 3) 
or a point mutant in the NPXY motif (T24-ELN744A; shown in bold, 
Fig. 4 A) at similar levels were assessed for their migration on 
vitronectin (left) or for survival within a collagen ECM (right). 
Migration was measured microscopically as the average wound 
closure plotted, as the mean   SE of six sites on a vitronectin-coated 
plate after 24 h. Collagen survival was assessed microscopically by 
direct cell counting to assess exclusion of PI (five fields per gel, 
three gels). The mean   SE of three experiments are shown. (E) 
Membrane-anchored forms of the integrin cytosolic domain induce 
apoptosis. COS7 cells were transfected with three different  3 
cytoplasmic domain constructs; Tac- 3, as well as a second 
membrane-anchored, GFP- 3, and an unanchored, His- 3, variant 
of the  3 cytoplasmic domain. Detergent lysates of these cells were 
subjected to immunoblotting to assess PARP cleavage (top) and to 
confirm expression of the individual constructs (GFP, top; Tac/His, 
bottom). One of two similar experiments is shown. (F) Cell 
spreading was assessed via analysis of digital images of cells 464 The Journal of Cell Biology | Volume 155, Number 3, 2001
gels. Similar to our previous findings (Fig. 5, A and B), crmA
expression suppressed IMD, whereas DN–FADD, DN–cas-
pase-9, and bclxl were unable to block this form of apoptosis
(Fig. 5 D). Together, these findings suggest that initiation of
IMD does not require the components of the stress caspase
cascade, but does depend upon the activation of initiator
caspases in a manner independent of death receptors.
Unligated integrins activate caspase-8–like activity
To explore the mechanism(s) by which unligated integrins
might activate caspase and induce IMD, we next examined
the subcellular localization of activated caspases during IMD.
Integrin-initiated caspase activity was visualized by labeling
with FAM-VADfmk, which covalently and fluorescently la-
bels activated caspases. Visual assessment of cells undergoing
IMD revealed a punctate distribution of caspase-associated
fluorescence that colocalized with unligated  3 integrin tail
on the cell surface (Fig. 6 A). In contrast, Tac- 5, which
does not induce IMD, appeared diffusely on the cell surface
and did not colocalize with caspase activity (Fig. 6 A). Nota-
bly, caspase activity was also found to be reduced in or absent
from Tac- 3–expressing cells that were attached to sub-
strate-immobilized Tac antibody (Fig. 6 A, left). In these
cells, Tac- 3 expression was found to be redistributed and
predominantly at the cell–substrate interface, as determined
by confocal z-section analysis. The series of collected, inte-
grin-containing z-sections were subjected to digital image
analysis by blinded observers to assess possible colocalization
between the integrin and active caspase (Fig. 6 B). Only un-
der conditions that induced IMD (unligated Tac- 3), was
significant colocalization observed between caspase and inte-
grin (coefficient of colocalization   0.49   0.07; P   0.01).
To identify the caspases activated during this process,
COS7 cells undergoing IMD were labeled with a biotin-
ylated caspase inhibitor (biotin-VADfmk), lysed, and ana-
lyzed for the presence of biotinylated products. Biotin-VAD
labeling revealed several discernible caspase forms, including
zymogen and activated forms of caspase-3 and caspase-8
(Fig. 6 C). Characterization of the caspase activity present in
cells undergoing IMD confirmed a caspase-8–like (“IETD-
ase”) activity that was suppressed by substrate ligation of the
integrin chimera (Fig. 6 D). Caspase activity was not ele-
vated in cells expressing the control  5 integrin chimera (Fig.
6 D). However, IETDase activity is not absolutely specific to
caspase-8 and could be mediated by caspase-3. Therefore,
subsequent cell fractionation studies (Chen et al., 2000) were
performed to confirm that caspase-8 was processed to its ac-
tive form in these cells. Interestingly, the processed form of
caspase-8 became highly enriched within the membrane and
cytoskeletal/nuclear fractions in cells expressing the  3 inte-
grin tail, but not in cells expressing a truncation mutant that
fails to induce apoptosis, GFP- 3
 717 (Fig. 6 E).
Recruitment of caspase-8 by integrin   subunit tails
The external clustering of death receptors, such as Fas, leads
to formation of a death-inducing signaling complex (DISC),
which recruits and activates caspase-8 (Scaffidi et al., 1999).
To determine if integrins induced apoptosis in a manner
Figure 5. IMD depends on initiator 
caspase activity. (A) Executioner caspase 
activity is blocked by crmA but not by 
inhibitors of stress or Fas-mediated 
apoptosis. Coexpression of crmA, 
DN-FADD, Bclxl, or catalytically 
inactive caspase-9, DN Casp 9 (4  g) 
with the proapoptotic Tac- 3 construct 
(2  g) was performed to determine 
whether these checkpoint-specific 
apoptosis inhibitors could suppress IMD. 
Cells were assessed after 36 h using the 
activation of executioner caspase 
activity (PARP cleavage immunoblot 
assay) as an indicator. Data are 
expressed as a ratio of PARP cleavage 
found in (Tac- 3   inhibitor) to that 
observed in (Tac- 3   control vector) 
transfected cells, and represents the 
normalized results of three to four 
independent experiments. To confirm 
that constructs with no activity in IMD 
were functional, apoptosis was also 
induced via Fas overexpression (2  g; 
hatched bars), or Bad expression (1  g; 
gray bars). (B) Cell viability is maintained by crmA. Cells were allowed to express constructs (as per A, above), but in this case apoptosis was 
quantified by FACS
®. Cells harvested 36 h after transfection were labeled with Alexa dye–conjugated anti-CD25 (7G7B6-Alexa488) to label 
Tac-expressing cells. Dead cells were identified by uptake of PI (500 ng/ml). Results are expressed as the percentage of dead, Tac-expressing 
cells in each group, and represent the mean   SE of two experiments. (C) Peptides that inhibit stress-induced apoptosis are not active in IMD. 
COS7 cells, induced to die via expression of Tac- 3, were treated with 40  M of caspase-inhibitory peptides (zIETDfmk, zDEVDfmk, or 
zLEHDfmk) as a single dose 12 h after transfection, and then monitored for executioner caspase activation, i.e., PARP cleavage, 24 h later. 
Data are expressed relative to cells treated with diluent (DMSO) alone and represent the mean   SD of two experiments. (D) IMD induced by 
endogenous integrins is blocked by crmA. COS7 cells coexpressing Ds-RED fluorescent protein, a transfection marker, and checkpoint-
specific inhibitors of apoptosis, as listed above, were assessed for survival after a 48 h culture on collagen gels in complete growth medium 
via morphologic scoring, as described (Fig. 2). Data shown is the mean survival   SE. A representative experiment of two is shown.Apoptosis of adherent cells by unligated integrins | Stupack et al. 465
analogous to death receptors, COS7 cells were held in sus-
pension and treated with anti- v 3 integrin–antagonist an-
tibodies. The cells were lysed and integrin complexes were
then immunoprecipitated from the resulting lysates and sub-
jected to analysis for DISC components. Although both the
zymogen and active forms of caspase-8 were observed in in-
tegrin immunoprecipitates (Fig. 7 A), FADD was not de-
tected (unpublished data). Clustering of a control trans-
membrane protein, LDL-like receptor protein (LRP), which
is expressed at levels similar to integrin  v 3 on COS7 cells,
did not recruit either form of caspase-8 (Fig. 7 A).
Since the cytoplasmic domain of the integrin was suffi-
cient to induce apoptosis (Fig. 3) as well as recruitment and
activation of caspase-8 at the cell membrane (Fig. 6, A and
E), we next determined whether the transmembrane domain
and cytoplasmic tail of  3 integrin was sufficient to mediate
association with caspase-8. Immunoprecipitation of GFP- 3
expressed in COS7 cells revealed associated caspase-8 (Fig. 7
B), which was not observed in immunoprecipitates from cells
expressing the inactive GFP- 3
 717 mutant. Moreover, asso-
ciation of the integrin tail with caspase-8 was functionally
important, as no association was observed with nonapoptotic
integrin  5, and integrin ligation events that blocked apop-
tosis also disrupted the association of caspase-8 with integrin
 3 (Fig. 7 C). Finally, integrin and caspase-8–containing
complexes did not include caspases-1, -3, -6, -7, and -10 as
detected by immunoblot analysis (unpublished data).
To determine whether endogenous integrins induced
IMD by recruitment of caspase-8, native  v 3 complexes
were isolated from endothelial cells undergoing apoptosis in
collagen gels and assessed for the presence of caspase-8. En-
dothelial cells cultured in collagen or in suspension (positive
Figure 6. Caspase-8 is recruited to the membrane 
and becomes activated during IMD. (A) Integrin 
tails colocalize with caspase activity during IMD. 
The cellular location of death-inducing integrin 
tails and active caspases was assessed by immu-
nofluorescence using a 1024 Bio-Rad confocal 
microscope. Cells were induced to undergo apop-
tosis by integrin cytoplasmic domain expression, 
or were rescued by ligation (as described in Fig. 4 
G). Before fixation in PBS/4% paraformaldehyde, 
cells were labeled with FAM-VAD in serum free 
media for 60 min to label active caspases (fluores-
cein, green channel). Cells were then probed for 
Tac expression (monoclonal antibody 7G7B6, red 
channel). Signals for each image were gathered 
serially as independent scans using the 488 nm 
(middle row) and 566 nm (top row) laser lines. 
Colocalization within the z-sections is shown as a 
yellow/orange signal (bottom row). (B) Confocal 
images of COS7 cells expressing the Tac–integrin 
chimeras described in A were acquired by blinded 
observers. The coefficient of colocalization 
between the 488 and 566 nm signal within the 
integrin-containing z-sections was determined 
(Bio-Rad Lasersharp Software). The mean   SE of 
10 random fields for each group are plotted. (C) 
Caspase-8 and -3 are labeled during IMD. COS7 
cells induced to die by the expression of integrin 
tail were incubated with biotin-VAD to label active 
caspase. Active caspases were then isolated with 
avidin-Sepharose and resolved via SDS-PAGE on 
8–16% nonreducing gradient gels. Immunoblotting 
was performed with polyclonal rabbit antisera to 
caspases-3 (lane 2) or -6 (lane 4) (control and not 
detected, respectively) or monoclonal antisera to 
caspase-8 (lane 3). (D) Caspase-8–like activity is 
elevated during IMD. Lysates from COS7 cells 
expressing Tac constructs with either the integrin 
 5 cytoplasmic domain (gray circles), the integrin 
 3 cytoplasmic domain (open circles), or mock 
transfectants (open squares) were assessed for their 
relative ability to cleave the caspase-8 substrate, 
IETD-pNA. The induced IETDase activity in the 
Tac- 3 expressing cells was suppressed by 
substrate ligation of the chimera (as described in 
Fig. 2 G), as shown (black circle). (E) The subcellular 
distribution and predominant forms of caspase-8 
change in cells undergoing IMD. Cell fractionation 
of COS7 cells expressing GFP- 3 (induces IMD) or GFP- 3
 717 (inactive truncation) was performed 36 h after transfection with the individual 
constructs (4  g). The relative distribution and forms of caspase-8 were assessed by immunoblot analysis of the cytosolic (Csol), membrane 
(Mem), and cytoskeletal/nuclear (Cskn) fractions. Relative molecular mass (kD) of the detected species is indicated. Bar, 10  m.466 The Journal of Cell Biology | Volume 155, Number 3, 2001
apoptosis control) were enriched for the presence of cas-
pase-8 (Fig. 7 D), whereas complexes isolated from endothe-
lial cells cultured in a fibrin gel displayed a dramatic decrease
in both caspase-8 (Fig. 7 D) and apoptosis (Fig. 2 A). Thus,
cells expressing high levels of endogenous  v 3, in an inap-
propriate ECM, can be induced to die by the death recep-
tor–independent, and presumably, FADD-independent, re-
cruitment and activation of caspase-8. Conversely, this
process is prevented in the presence of an integrin-appropri-
ate ECM.
Discussion
Integrins are known to promote the survival of various cell
types in culture, and have been shown to be sufficient at
mediating the “anchorage dependent” component of cell
growth (Schwartz, 1997). Recently, integrin-mediated adhe-
sion has also been demonstrated to promote cell survival in
response to stress-associated apoptotic triggers such as star-
vation, growth factor withdrawal, and chemical mediators
(Ilic et al., 1998; Moro et al., 1998; Bonfoco et al., 2000). In
these cases, integrin signaling proceeds via focal adhesion ki-
nase to the nucleus, allowing sustained cell survival under
conditions that might otherwise induce death, i.e., survival
signaling (Ilic et al., 1998). In contrast, data is provided here
that demonstrates that integrins themselves, when unligated,
can trigger apoptosis of adherent cells in the absence of any
other death-inducing stimuli. This form of apoptosis,
termed IMD, is biologically and biochemically distinct from
anoikis, which is defined as death due to cell detachment
from substrate (Frisch and Francis, 1994).
IMD
IMD depends upon the ability of the integrin   subunit to
recruit caspase-8 to the cell surface in a FADD-independent
manner. These findings may explain our previous observa-
tions in vivo, where angiogenesis was suppressed in tissues
treated with  v 3 integrin antagonists due to an induction
of apoptosis of angiogenic endothelial cells (Brooks et al.,
1994b; Stromblad et al., 1996; Storgard et al., 1999). In re-
cent studies, we observed that inhibitors of caspase-8, but
not caspase-9, restored neovascularization in  v 3 antago-
nist–treated angiogenic tissues (unpublished data). Thus,
cells that interact with an inappropriate ECM, or those ex-
posed to integrin antagonists may succumb to IMD. Inter-
estingly, while  1 and  3 integrins can promote this pro-
cess,  5 apparently does not (Fig. 3 D). Therefore, distinct
integrins may have different capacities to induce apoptosis
due to regulatory regions present elsewhere in the integrin
heterodimer.
IMD was observed in several cell lines, including COS7,
CS1, HEK, HTB, and HUVEC. However, it is noteworthy
that some cells examined, including CHO-K1 and HeLa,
were resistant to IMD (unpublished observations). Resis-
tance to IMD may occur, in vivo or in vitro, for several rea-
sons. Clearly, cell type–specific or clonal variations result in
cultured cells having varied capacities to secrete or otherwise
remodel their immediate ECM. Furthermore, not all cells
express appropriate caspases, such as caspase-8, or may ex-
Figure 7. Caspase-8 associates with integrins during IMD. 
(A) Caspase-8 associates with native integrin  v 3. Integrin  v 3 
and LRP complexes are expressed at similar levels on COS7 cells 
(unpublished data) and were subjected to clustering and 
immunoprecipitation followed by immunoblot analysis for 
caspase-8 to determine if caspase-8 was recruited to an integrin 
DISC-like complex (Scaffidi et al., 1999). (B) Integrin cytosolic 
domains are sufficient to recruit caspase-8. Expressed GFP- 3 
(proapoptotic) or GFP- 3
 717 (inactive) constructs were subjected 
to immunoprecipitation with GFP-Sepharose followed by 
immunoblot analysis for the presence of associated caspase-8 
(top) or the GFP chimera (bottom). (C) Ligation of integrin 
disrupts caspase association. Integrin-expressing COS7 cells 
(Tac- 1, unligated Tac- 3, Tac- 5) and Tac- 3–expressing 
cells replated onto anti-Tac substrate (ligated Tac- 3) (as 
described in Fig. 4 F) were lysed and subjected to immunopre-
cipitation with anti-Tac monoclonal antibody. The precipitates 
were resolved via SDS-PAGE and analyzed for the presence of 
associated caspase-8 (top) or Tac (bottom) via immunoblotting. 
(D) An  v 3 integrin ligand rescues apoptosis and interrupts 
caspase-8 recruitment to integrins in a three-dimensional ECM. 
HUVECs were cultured in three-dimensional fibrin or collagen 
gels, or maintained in suspension (apoptosis positive control) 
for 16 h. Endothelial cells were then recovered from the gels, 
lysed, and subjected to immunoprecipitation using LM609 
(anti- v 3). The precipitates were resolved and analyzed for the 
presence of caspase-8 by immunoblotting, as described above.Apoptosis of adherent cells by unligated integrins | Stupack et al. 467
press inhibitors such as c-flip (Aoudjit and Vuori, 2001). In
these cases, integrin antagonism may induce apoptosis by
other means. For example, integrin antagonism also leads to
the activation of the tumor suppressor p53 (Stromblad et al.,
1996). Since p53 complexes with caspase-8 (Ding et al.,
2000), it may have a direct role in IMD. However, tran-
scriptional activation of p53 also elicits stress-mediated
death via activation of caspase-9 (Soengas et al., 1999). Ac-
cordingly, neurons that express little or no caspase-8 eventu-
ally undergo apoptosis in response to integrin antagonism
via the stress–caspase-9 pathway (Bonfoco et al., 2000).
In addition, a variety of other proteins that can play key
regulatory roles in the induction of, or resistance to, apopto-
sis have been identified. For example, tumor cells that are
anchorage independent may be resistant to IMD. However,
the expression of integrin  v 3 on CS1 3 cells was able to
induce IMD in an otherwise anchorage-independent cell
(Fig. 1 D). These findings suggest that specific integrin an-
tagonists may be useful as antitumor agents, as suggested by
others (Ruoslahti, 1997; Curley et al., 1999).
Physiological roles for IMD
IMD would be predicted to occur during tissue remodeling
associated with development, wound repair, or inflamma-
tion to ensure that only appropriate cells remain viable
within a given tissue microenvironment. For example, the
ECM is dramatically remodeled during the involution/epi-
thelial cell regression phase following weaning (Sympson et
al., 1994). During this apoptotic process, epithelial cells un-
dergo caspase activation in a  1 integrin–dependent manner
(Boudreau et al., 1996). Antagonism of  1 also results in
chondrocyte apoptosis during ECM remodeling associated
with differentiation (Hirsch et al., 1997). In agreement with
these studies, we show that the cytoplasmic domain is suffi-
cient to induce IMD. However, it is not clear why apoptosis
is more often associated with specific  1 integrins. In partic-
ular, the overexpression of integrin  5 1 has been docu-
mented to suppress tumorigenicity (Giancotti and Ruo-
slahti, 1990; Varner et al., 1995) and/or angiogenesis (Kim
et al., 2000), possibly through the induction of apoptosis
(Plath et al., 2000). The effect is reversed by fibronectin, a
ligand for  5 1 (Varner et al., 1995). In contrast, prolifera-
tive tumors with an elevated expression of  5 1 in vivo,
which would be IMD resistant, might therefore be associ-
ated with a poorer prognostic outcome (Adachi et al., 2000).
Thus, IMD may be an important regulatory event under
many physiological circumstances in vivo.
Role of caspase-8 in IMD
Our findings indicate that caspases function downstream of
unligated integrins in the induction of IMD. Thus, inhibi-
tion of caspase-8 via peptide or protein (crmA) antagonists
results in reduced IMD, whereas increased expression of un-
ligated integrins increases caspase activation and apoptosis.
Evidence is provided that caspase-8 can directly or indirectly
interact with integrin   subunit cytoplasmic domain, and
this interaction contributes to the activation of the caspase.
Unligated integrins tend to cluster on the cell surface in a
manner dependent upon integrin expression level, however,
these integrins are not associated with focal adhesion kinase
or tethered by the cytoskeleton (unpublished data). These
untethered clusters of integrin may serve to recruit sufficient
numbers of caspase-8 zymogens to facilitate proximity-
induced activation of the initiator caspase cascade (induced
proximity model; Salvesen and Dixit, 1999) in a death re-
ceptor–independent manner. Although integrins may be less
efficient than death receptors in this respect, it is noteworthy
that other methods of “clustering” caspase-8 serve to activate
it, including mutation, to add multimerization domains
(MacCorkle et al., 1998; Memon et al., 1998; Muzio et al.,
1998; Fan et al., 1999), and overexpression strategies (Sten-
nicke and Salvesen, 1999). Supporting this notion, integrin
cytoplasmic domain constructs that provide no localization
signal, e.g., His- 3, also fail to induce IMD, whereas, in-
creasing the number of unligated integrins (Figs. 1 B and 3
B) or blocking multiple integrins ( v 3 and  1 integrins;
Fig. 2 F), augmented the incidence of IMD. Thus, the in-
creased apoptotic rate seen with combined anti- v 3/anti-
 1 treatment in collagen gels (Fig. 2 F) may be due to the
increased sum quantity of unligated integrins (in this case,
both  3 and  1).
Integrin- or caspase-deficient mice frequently show devel-
opmental defects and/or lethality (Fassler et al., 1996;
Zheng and Flavell, 2000). Although  v 3 is proapoptotic
when unligated (this work), or antagonized (Brooks et al.,
1994b; Brassard et al., 1999; Storgard et al., 1999), it is,
nonetheless, nonessential for the viability of humans (Coller
et al., 1991) or mice (Hynes and Hodivala-Dilke, 1999).
Why then, should  v 3 continue to be expressed on inva-
sive tissues in the broad range of species observed? Integrin
 v 3 may function during invasive processes as a biosensor,
providing positive feedback to the cell during “productive”
interactions, i.e., in a permissive ECM (Ilic et al., 1998),
while inducing death by triggering caspase recruitment/acti-
vation in those cells that enter an inappropriate microenvi-
ronment. Disrupting expression of integrin  v 3 would
thus only remove one of several possible triggers for apopto-
sis. This capacity to selectively suppress or promote apopto-
sis distinguishes integrins from the death receptor and stress
apoptotic pathways, and suggests that integrins may be
grouped within a third emerging category of apoptotic trig-
gers, the dependence receptors (Bredesen et al., 1998).
It is still not known whether accessory molecules may be
involved in the regulation of this interaction. However, not
all cells were subject to IMD, and not all integrins are
proapototic. Thus, it is likely that extended investigations
will reveal both cell and integrin-specific factors that govern
the induction of this cascade. Nevertheless, this novel apop-
totic trigger, which is regulated by integrin repertoire and lo-
cal ECM composition, provides a new means to account for
cell death and survival associated with tissue remodeling and
homeostasis.
Materials and methods
Cell lines and three-dimensional cell culture
T24-E carcinoma cells (formerly designated ECV-304) (catalog number
1998; American Type Culture Collection) were serially sorted to iso-
late stable,  3 integrin–lacking (T24-EL) populations.  3 integrin expres-
sion was reconstituted by transfection of pcDNA-Neo 3 or pcDNA-468 The Journal of Cell Biology | Volume 155, Number 3, 2001
Neo 3(N744A) followed by neomycin selection (500  g/ml) with FACS
®
sorting to eliminate neomycin-resistant but nonexpressing cells from the
population as we have previously done for the CS1 cell line (Filardo et al.,
1995). Integrin function was also assessed via transwell migration (Cho
and Klemke, 2000), wound assay (Hauck et al., 2001), or adhesion as-
says (Filardo et al., 1995), as described. T24E, T24EL, T24-EL 3, COS7,
or HUVE cells were microcultured in complete medium either within a
three-dimensional collagen (Vitrogen; Cohesion Technologies) (Cho and
Klemke, 2000) or thrombin-elicited fibrin gel (American Diagnostica) (500
cells/10  l), or on the surface of these immobilized gels after washing/
equilibrating with complete medium for 30 min. Cells were subsequently
cultured in complete media (M199, 20% FBS, endothelial cell growth sup-
plement for HUVECs, RPMI 1640, 5% FCS for CS1 lines, DME, 5% FBS for
all other cell lines, all supplemented with gentamycin and glutamine, min-
imal amino acids and pyruvate; Sigma-Aldrich). Three methods were used
to confirm that death occurred via apoptosis in the gels. Dead or dying
cells were identified using nuclear dyes (PI) to visualize nuclear collapse.
Morphological scoring (satellite/condensation) assays (Cho and Klemke,
2000) were performed using Cell Tracker-Green–labeled cells (Molecular
Probes). Cell Tracker labeling was proceeded by a 10-min incubation with
2  M Cell Tracker in serum-free medium before assay. Annexin-V (CLON-
TECH Laboratories, Inc.) reactivity was used as an early marker of apopto-
sis and identified dying cells before spreading was lost. These methods
yielded comparable results. Biochemical analysis of PARP cleavage was
performed in scaled-up gels (250,000 cells/5 ml   10, 100 mm plates);
cells were extracted from collagen by brief treatment with PBS/0.25% bac-
terial collagenase (Sigma-Aldrich) or from fibrin by brief plasmin (Sigma-
Aldrich) treatment at 37 C before washing twice in PBS and immunopre-
cipitation studies, described below.
Constructs and gene delivery
Deficient adenoviral antisense constructs containing a CMV-driven ORF
complementary to the first 508 bp of  3 or nonsense (empty read through)
constructs were generated by recombination of pAdCI/pJM17 plasmids in
U293 (E1 complementary) cells. HUVECs were infected at a multiplicity of
infection of  100 pfu/cell, yielding 100% infection as assessed by infec-
tion with adenoviruses encoding an Ad-  gal reporter gene. The pCI-Neo-
Tac- 3, pCI-NeoTac- 5, and pCI-NeoTac- 1 constructs were created by
ligation of integrin cytoplasmic domains to the extracellular and trans-
membrane domains of Tac/CD25, as originally reported (LaFlamme et al.,
1992). The truncated chimeras were created by introduction of inframe
stop codons in the integrin coding sequence, as described (Filardo et al.,
1995). The His- 3 construct was constructed by in frame expression of the
 3 cytoplasmic domain after the His tag in pcDNA3.1/V5/His A vector (In-
vitrogen). The GFP- 3 chimeras were constructed essentially as described
for  1 (Smilenov et al., 1999) but included the signal sequence and trans-
membrane/cytoplasmic domains of integrin  3, rather than  1, expressed
in the pEGFP-C3 vector (CLONTECH Laboratories, Inc.). The bclxl, bad,
and crmA constructs in pCMV5 were the gifts of S. Huang (The Scripps Re-
search Institute, La Jolla, CA), independent DN-FADD constructs that lack
the DED domains were obtained from H. Duan (University of Michigan,
Ann Arbor, MI) and E. Li (The Scripps Research Institute, La Jolla, CA).
DN–caspase-9 and Fas were provided by G. Salvesen (The Burnham Insti-
tute, La Jolla, CA). For the induction of death by chimeras, subconfluent
( 30% confluent) cell cultures were transfected via lipofectamine or lipo-
fectamine plus, as per the manufacturer’s instructions (Invitrogen), and har-
vested at the time points described. For PARP cleavage studies, cells were
lysed on the plate in complete RIPA. For PI studies, cells were briefly
trypsinized and collected. Cells were labeled with Alexa-488–conjugated
anti-CD25 (7G7B6), and PI was added to assess loss of viability. To avoid
misinterpretation of DNA toxicity in coexpression experiments, only 2  g
of pCI-NeoTac- 3 was cotransfected with 4  g of the specific apoptotic in-
hibitor, as described in the cotransfection/rescue studies. Expression of
these constructs was confirmed by FACS
® and/or immunoblotting, as de-
scribed in the legends.
Assessment of apoptotic indicators
For FACS
® analysis of apoptosis, only cells remaining adherent on tissue
culture plastic after washing with PBS were trypsinized briefly, quenched
in complete media, and again washed in PBS, before annexin-V staining
and assessment on a FACScan
® flow cytometer (Becton Dickinson). Tac-
expressing cells (Alexa 594, FL3) were identified as apoptotic by annexin
staining (FITC, FL1). For PARP cleavage studies, cells were lysed in RIPA
(Filardo et al., 1995), cell debris was pelleted at 16000 g, and lysates were
analyzed by immunoblotting (2  g/ml PARP; catalog number 66391A;
PharMingen), 5  g/ml Tac mAb 7G7B6 (American Type Culture Collec-
tion), rabbit antisera to GFP (Santa Cruz Biotechnology, Inc.) via species-
specific secondary HRP-conjugated antiserum (Jackson ImmunoResearch
Laboratories) and Lumigen PS-3 improved chemiluminescent substrate
(Lumigen). The 115- and 85-kD caspase-processed forms were quantitated
(IP Lab Spectrum Software) within each experiment. Data was expressed as
a ratio of p85/p115 for the lane (construct expressing and nonexpressing
cells, inclusive). Caspase activity isolated from total cell populations was
also assessed using LEHD-pNA (unpublished data) and IETD-pNA colori-
metric assays according to the manufacturer’s protocol (Chemicon).
Cell spreading
Digital images of cells were captured serially during spreading using a
Princeton Instruments Micromax CCD camera (Roper Scientific, Inc.). Cell
spreading was quantified by segmentation of GFP or GFP- 3–expressing
cells (COS7) or Cell Tracker-Green–labeled cells (HUVEC) with automated
area calculations using IP Lab Spectrum Software (Scanalytics). The aver-
age cell spreading was determined from the cell area on 10 random fields
for each time point.
Adhesion to antibody-coated substrate
Anti-Tac (5  g/ml in PBS, pH 8.1) was allowed to coat nontissue culture
dishes or coverslips overnight at 4 C. Surfaces were washed twice with
PBS before cell adhesion. COS7 cells expressing Tac 12 h after transfection
with 40 ng Tac- 3 pCI-Neo/cm
2 were trypsinized, quenched, and allowed
to seed the anti-Tac–coated plates in serum-free media. After 1 h at 37 C,
unattached cells were removed by washing with serum-free media, and
complete media was added. Cells that were lysed and analyzed for inte-
grin expression and PARP cleavage (as described) were compared 24 h
later to control populations still adherent on their original 100-mm dish.
Membrane isolation and immunoprecipitations
Cellular fractionation was performed as previously described (Chen et al.,
2000). Pelleted membranes were resolubilized in Laemmli buffer for gel
analysis, or in 1  protease inhibitor cocktail (1% Triton X-100, 25 mM
Hepes, pH 7.4; Boehringer) for immunoprecipitation with anti-GFP aga-
rose (Santa Cruz Biotechnology Inc.). Alternately, integrin–caspase com-
plexes were immunoprecipitated by adding precipitating antisera (poly-
clonal anti- 3, polyclonal anti-GFP, or polyclonal anti-LRP) to form
DISC-like structures, followed by lysis on ice in 1% triton, as described
(Scaffidi et al., 1999). Caspase immunoblotting was performed with anti-
caspase-8 polyclonal (Chemicon; StressGen Biotechnologies) or mono-
clonal (Calbiochem; mAb3) antibodies. These antibodies recognize both the
zymogen and active forms of the caspase. The potential presence of other
caspases was excluded by immunoblotting for the presence of caspases-1,
-3, -6, -7, -9, and -10 using specific rabbit polyclonal antisera (Chemicon;
StressGen Biotechnologies) that recognize both zymogen and active forms
of the caspase. Even though caspases-3, -8, and -9 were the predominant
caspases in COS7 cells, all but caspase-1 and -10 were detected.
Caspase labeling and inhibition with peptides 
The methyl ester–derived peptide inhibitors zIETDfmk, zDEVDfmk, and
zLEHDfmk (Calbiochem) or zVADfmk (Bachem) were reconstituted in
DMSO (50 mM) and diluted as appropriate. Apoptosis was assessed in
subconfluent 33-mm dishes of COS7 cells expressing submaximal quanti-
ties of death-inducing constructs (1–2  g of Tac- 3/pCI-NEO) using 40–80
 M peptides (or DMSO diluent) by visual scoring (not shown) and via the
cleavage of the executioner caspase substrate PARP. Fluorescent FAM-
VAD (InterGen) labeling of caspase in Tac-expressing cells was performed
according to the manufacturer’s specifications, followed by fixation (PBS/
1% paraformaldehyde) and blocking (PBS/3%BSA) for 1 h at 37 C, and de-
tection of Tac with Alexa-594–conjugated (Molecular Probes) mAb 7G7B6
(0.5  g/ml) for 1 h. Cells were washed three times with PBS and examined
with a Bio-Rad Laboratories 1024 confocal microscope. Biotinylation of
active caspases with biotin-VADfmk was performed by first removing se-
rum-containing media, washing the cells once, and incubating at a final
concentration of 10  M biotin-VAD in DME for the final hour. Biotinylated
complexes were isolated with avidin-Sepharose, identified by probing
with antibiotin horseradish peroxidase–conjugated monoclonal antibody
(Sigma-Aldrich), and developed via CDP-star reagent (Applied Biosys-
tems). Membranes were subsequently reprobed with caspase-specific anti-
sera (-3, -6, -7, -8, -9) as described.
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